Profile of:

Joerg  Ermann

Full name: Joerg  Ermann

Current country: United States

Membership level: Full

Type of membership: Member

Number of publications: 9

A glance into the future of diagnosis and treatment of spondyloarthritis (2022)

Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs (2022)

The impact of genetic background and sex on the phenotype of IL-23 induced murine spondyloarthritis (2021)

Recognizing Axial Spondyloarthritis: A Guide for Primary Care (2020)

Spondyloarthritis evolution: what is in your history? (2020)

Pathogenesis of Axial Spondyloarthritis – Sources and Current State of Knowledge (2020)

Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W) (2020)

Incorporating natural language processing to improve classification of axial spondyloarthritis using electronic health records (2020)

Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States (2019)